PillHydromorphone Hydrochloride
Brands: Dilaudid · Hydromorphone Hydrochloride
4 active makers
soon
soon
soon
soon
US acquisition costNADAC · per unit
Average across 8 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
Who makes it4 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hospira, Inc. | unknown | 11 | SUPPLYING |
| Fresenius Kabi USA, LLC | unknown | 10 | SUPPLYING |
| Teva Parenteral Medicines, Inc. | unknown | 3 | SUPPLYING |
| Hikma Pharmaceuticals USA Inc. | unknown | 1 | SUPPLYING |
Regulatory & supply eventsFDA · US
Shortages, recalls, and registration changes attached to this drug concept.
- Feb 7, 2018RECALLRecall (Class I): Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. …
Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked. — Recalling firm: Pfizer Inc. — Nationwide in the USA
- Feb 7, 2018RECALLRecall (Class I): Hydromorphone, Hydrochloride, Injection, USP CII, 10 mg/mL, Rx Only, 1 mL Single-dose Vial, High Potency Formulation. M…
Non-Sterility: Confirmed customer complaints of glass product container vials that may be empty or cracked. — Recalling firm: Pfizer Inc. — Nationwide in the USA
- Nov 1, 2017SHORTAGEDrug shortage: Hydromorphone Hydrochloride Injection (Teva Pharmaceuticals USA, Inc.)
Hydromorphone Hydrochloride Injection — reported in shortage by Teva Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.
- Nov 1, 2017SHORTAGEDrug shortage: Hydromorphone Hydrochloride Injection (Hikma Pharmaceuticals USA, Inc.)
Hydromorphone Hydrochloride Injection — reported in shortage by Hikma Pharmaceuticals USA, Inc.. Therapeutic category: Analgesia/Addiction.
- Oct 31, 2017SHORTAGEDrug shortage: Hydromorphone Hydrochloride Injection (Hospira, Inc., a Pfizer Company)
Hydromorphone Hydrochloride Injection — reported in shortage by Hospira, Inc., a Pfizer Company. Therapeutic category: Analgesia/Addiction.
- Oct 31, 2017SHORTAGEDrug shortage: Hydromorphone Hydrochloride Injection (Fresenius Kabi USA, LLC)
Hydromorphone Hydrochloride Injection — reported in shortage by Fresenius Kabi USA, LLC. Therapeutic category: Analgesia/Addiction.
- Aug 22, 2017RECALLRecall (Class II): HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc.…
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process. — Recalling firm: Pfizer Inc. — United States Nationwide (including Puerto Rico) and Singapore
- Jul 26, 2017RECALLRecall (Class II): Hydromorphone Hydrochloride Injection, USP, 50 mg/5 mL (10 mg/mL), 5 mL Single Dose Vial.(10 vials per carton NDC 0703-…
Presence of Particulate Matter: Silicone oil — Recalling firm: HOSPIRA INC, LAKE FOREST — Nationwide in the USA
- Jul 26, 2017RECALLRecall (Class II): Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial per Carton, 100 vials per c…
Presence of Particulate Matter: Silicone oil — Recalling firm: HOSPIRA INC, LAKE FOREST — Nationwide in the USA
- Jul 26, 2017RECALLRecall (Class II): Hydromorphone Hydrochloride Injection, USP, 500 mg/50 mL (10 mg/mL), 50 mL Single Dose Vial. Mfd For: Teva Parenteral …
Presence of Particulate Matter: Silicone oil — Recalling firm: HOSPIRA INC, LAKE FOREST — Nationwide in the USA
- Oct 1, 2014RECALLRecall (Class II): Hydromorphone Hydrochloride Injection, USP, 10 mg/mL, Rx only, packaged in a) 1 mL Single-dose Vial (NDC 0703-0110-01),…
Lack Of Assurance Of Sterility: Confirmed customer complaints of glass product container vials that may be broken or cracked. — Recalling firm: Hospira Inc. — Nationwide
- Aug 15, 2012RECALLRecall (Class I): HYDROmorphone HCl Injection, USP, 2 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-cou…
Superpotent (Single Ingredient) Drug: The prefilled cartridge unit has been found to be overfilled and contain more than the 1 mL labeled fill volume. — Recalling firm: Hospira Inc. — Nationwide
- May 12, 2012RECALLRecall (Class I): HYDROmorphone HCl Injection, USP, 1 mg/mL, 1 mL fill in a 2.5 mL Carpuject prefilled cartridge unit, packaged in 10-cou…
Superpotent (Single Ingredient) Drug: Some of the prefilled cartridge units have been found to be overfilled and contain more than the 1 mL labeled fill volume. — Recalling firm: Hospira Inc. — Nationwide.